MHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination Prediction

In the field of cancer treatment, drug combination therapy appears to be a promising treatment strategy compared to monotherapy. Recently, plenty of computational models are gradually applied to prioritize synergistic drug combinations. However, the existing prediction models have not fully exploite...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Li, Guodong Lü, Chunhou Zheng, Renyong Lin, Yansen Su
Format: Article
Language:English
Published: Tsinghua University Press 2024-12-01
Series:Big Data Mining and Analytics
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/BDMA.2024.9020054
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846100745891348480
author Lei Li
Guodong Lü
Chunhou Zheng
Renyong Lin
Yansen Su
author_facet Lei Li
Guodong Lü
Chunhou Zheng
Renyong Lin
Yansen Su
author_sort Lei Li
collection DOAJ
description In the field of cancer treatment, drug combination therapy appears to be a promising treatment strategy compared to monotherapy. Recently, plenty of computational models are gradually applied to prioritize synergistic drug combinations. However, the existing prediction models have not fully exploited the multi-way relations between drug combinations and cell lines. Besides, the number of identified drug-drug-cell line triplets is insufficient owning to the high cost of in vitro screening, which affects the ability of models to capture and utilize multi-way relations. To address this challenge, we design the multi-view hypergraph contrastive learning model, termed MHCLSyn, for synergistic drug combination prediction. First, the synergistic drug-drug-cell line triplets are formulated as a drug synergy hypergraph, and three task-specific hypergraphs are designed based on the drug synergy hypergraph. Then, we design a multi-view hypergraph contrastive learning with enhancement schemes, which allows for more expressive and discriminative node representation learning on drug synergy hypergraph. After that, the representations of nodes indicating drug-drug-cell line triplets are inputted to fully connected network for making predictions. Extensive experiments show MHCLSyn achieves better performance than state-of-the-art prediction models on benchmark datasets and is applicable to unseen drug combinations or cell lines. Case study indicates that MHCLSyn is capable of detecting potential synergistic drug combinations.
format Article
id doaj-art-45930274d9284b7ab0d159cd0a7f11d2
institution Kabale University
issn 2096-0654
language English
publishDate 2024-12-01
publisher Tsinghua University Press
record_format Article
series Big Data Mining and Analytics
spelling doaj-art-45930274d9284b7ab0d159cd0a7f11d22024-12-29T15:36:22ZengTsinghua University PressBig Data Mining and Analytics2096-06542024-12-01741273128610.26599/BDMA.2024.9020054MHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination PredictionLei Li0Guodong Lü1Chunhou Zheng2Renyong Lin3Yansen Su4School of Artificial Intelligence, Anhui University, Hefei 230601, ChinaState Key Laboratory of Pathogenesis, Prevention, and Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, ChinaSchool of Artificial Intelligence, Anhui University, Hefei 230601, ChinaState Key Laboratory of Pathogenesis, Prevention, and Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, ChinaSchool of Artificial Intelligence, Anhui University, Hefei 230601, ChinaIn the field of cancer treatment, drug combination therapy appears to be a promising treatment strategy compared to monotherapy. Recently, plenty of computational models are gradually applied to prioritize synergistic drug combinations. However, the existing prediction models have not fully exploited the multi-way relations between drug combinations and cell lines. Besides, the number of identified drug-drug-cell line triplets is insufficient owning to the high cost of in vitro screening, which affects the ability of models to capture and utilize multi-way relations. To address this challenge, we design the multi-view hypergraph contrastive learning model, termed MHCLSyn, for synergistic drug combination prediction. First, the synergistic drug-drug-cell line triplets are formulated as a drug synergy hypergraph, and three task-specific hypergraphs are designed based on the drug synergy hypergraph. Then, we design a multi-view hypergraph contrastive learning with enhancement schemes, which allows for more expressive and discriminative node representation learning on drug synergy hypergraph. After that, the representations of nodes indicating drug-drug-cell line triplets are inputted to fully connected network for making predictions. Extensive experiments show MHCLSyn achieves better performance than state-of-the-art prediction models on benchmark datasets and is applicable to unseen drug combinations or cell lines. Case study indicates that MHCLSyn is capable of detecting potential synergistic drug combinations.https://www.sciopen.com/article/10.26599/BDMA.2024.9020054synergistic drug combinationscell linesmulti-way relationsmulti-view hypergraph contrastive learning
spellingShingle Lei Li
Guodong Lü
Chunhou Zheng
Renyong Lin
Yansen Su
MHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination Prediction
Big Data Mining and Analytics
synergistic drug combinations
cell lines
multi-way relations
multi-view hypergraph contrastive learning
title MHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination Prediction
title_full MHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination Prediction
title_fullStr MHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination Prediction
title_full_unstemmed MHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination Prediction
title_short MHCLSyn: Multi-View Hypergraph Contrastive Learning for Synergistic Drug Combination Prediction
title_sort mhclsyn multi view hypergraph contrastive learning for synergistic drug combination prediction
topic synergistic drug combinations
cell lines
multi-way relations
multi-view hypergraph contrastive learning
url https://www.sciopen.com/article/10.26599/BDMA.2024.9020054
work_keys_str_mv AT leili mhclsynmultiviewhypergraphcontrastivelearningforsynergisticdrugcombinationprediction
AT guodonglu mhclsynmultiviewhypergraphcontrastivelearningforsynergisticdrugcombinationprediction
AT chunhouzheng mhclsynmultiviewhypergraphcontrastivelearningforsynergisticdrugcombinationprediction
AT renyonglin mhclsynmultiviewhypergraphcontrastivelearningforsynergisticdrugcombinationprediction
AT yansensu mhclsynmultiviewhypergraphcontrastivelearningforsynergisticdrugcombinationprediction